Satter Investment Management logo

Satter Investment Management

North America, Illinois, United States, Chicago

Description

Satter Investment Management is a principal investment firm specializing in investments in life sciences and medical technology companies.

Investor Profile

Satter Investment Management has made 10 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series C (40%)
  • Series A (20%)
  • Series Unknown (10%)
  • Post Ipo Equity (10%)
  • Post Ipo Secondary (10%)
  • Series B (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Health Diagnostics
  • Life Science
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Satter Investment Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Athenian Venture Partners
North America, Florida, United States, Fort Lauderdale
Co-Investments: 3
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 7
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 3
Kearny Venture Partners
North America, California, United States, San Francisco
Co-Investments: 4
Triathlon Medical Venture Partners
North America, Ohio, United States, Cincinnati
Co-Investments: 4
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 3
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 4
AgeChem Venture Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2

What are some of recent deals done by Satter Investment Management?

Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Post Ipo EquityJul 8, 2022
Amount Raised: $130,000,000
Aileron Therapeutics

Cambridge, Massachusetts, United States

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

BiopharmaBiotechnologyTherapeutics
Post Ipo SecondaryJan 6, 2021
Amount Raised: $35,900,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series CJul 1, 2020
Amount Raised: $100,000,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series CDec 19, 2018
Amount Raised: $75,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series UnknownMar 16, 2017
Amount Raised: $40,000,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series BJun 23, 2016
Amount Raised: $44,000,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series ADec 15, 2014
Amount Raised: $34,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series CApr 23, 2014
Amount Raised: $22,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series ANov 6, 2013
Amount Raised: $36,000,000
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series CJun 4, 2013
Amount Raised: $41,000,000